-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Bicycle Therapeutics, Lowers Price Target to $7

Benzinga·03/18/2026 14:03:05
Listen to the news
RBC Capital analyst Leonid Timashev maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Sector Perform and lowers the price target from $11 to $7.